Explore
Validate
Learn
ImmunohistochemistryAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PAB13466 - Provider product page
- Provider
- Abnova Corporation
- Proper citation
- Abnova Corporation Cat#PAB13466, RRID:AB_10550521
- Product name
- BCL10 polyclonal antibody
- Antibody type
- Polyclonal
- Antigen
- A synthetic peptide (conjugated with KLH) corresponding to amino acids 216-233 of human BCL10.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Vial size
- 1 mL
- Storage
- Store at 4°C. Do not freeze.
Submitted references BCL10 expression in normal and neoplastic lymphoid tissue. Nuclear localization in MALT lymphoma.
BCL10 gene mutation in lymphoma.
BCL10 is rarely mutated in human prostate carcinoma, small-cell lung cancer, head and neck tumours, renal carcinoma and sarcomas. MPT Collaborators, St George's Hospital Collaborators.
Ye H, Dogan A, Karran L, Willis TG, Chen L, Wlodarska I, Dyer MJ, Isaacson PG, Du MQ
The American journal of pathology 2000 Oct;157(4):1147-54
The American journal of pathology 2000 Oct;157(4):1147-54
BCL10 gene mutation in lymphoma.
Du MQ, Peng H, Liu H, Hamoudi RA, Diss TC, Willis TG, Ye H, Dogan A, Wotherspoon AC, Dyer MJ, Isaacson PG
Blood 2000 Jun 15;95(12):3885-90
Blood 2000 Jun 15;95(12):3885-90
BCL10 is rarely mutated in human prostate carcinoma, small-cell lung cancer, head and neck tumours, renal carcinoma and sarcomas. MPT Collaborators, St George's Hospital Collaborators.
Gill S, Broni J, Jefferies S, Osin P, Kovacs G, Maitland NJ, Eeles R, Edwards SM, Dyer MJ, Willis TG, Cooper CS
British journal of cancer 1999 Jul;80(10):1565-8
British journal of cancer 1999 Jul;80(10):1565-8
No comments: Submit comment
No validations: Submit validation data